MedTrace Logo

Pilot Study of a New Nicotine Replacement Therapy

NCT00764439 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 258

Last updated 2012-07-10

No results posted yet for this study

Summary

Pilot study of a new nicotine replacement therapy for smoking cessation.

Conditions

  • Smoking Cessation

Interventions

DRUG

Nicotine replacement therapy

Nicotine replacement therapy with Standard NRT user direction

DRUG

Nicotine replacement therapy

Nicotine replacement therapy with a Novel NRT user direction

Sponsors & Collaborators

  • McNeil AB

    lead INDUSTRY

Principal Investigators

  • Elisabeth Kruse, PhD · Global Medical Affairs & Clinical Research, McNeil AB, Sweden

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00764439 on ClinicalTrials.gov